Related Experiment Video

Updated: May 24, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and

Lora Boteva1, David L Morris, Josefina Cortés-Hernández

  • 1Division of Genetics and Molecular Medicine, Guy's Hospital, King's College London, UK.

American Journal of Human Genetics
|March 6, 2012
PubMed

Insights

Partial complement component C4 deficiency does not independently increase systemic lupus erythematosus (SLE) risk. This study found no causal link between partial C4 deficiency and SLE in European populations.

Area of Science:

  • Immunogenetics
  • Autoimmune Diseases
  • Complement System

Background:

  • Systemic lupus erythematosus (SLE) is a complex autoimmune disease with known genetic risk factors.
  • Complete deficiency of complement component C4 (C4) is a strong genetic risk factor for SLE.
  • The role of partial C4 deficiency in SLE pathogenesis remains unclear, potentially confounded by linkage disequilibrium.

Purpose of the Study:

  • To investigate whether partial C4 deficiency is an independent genetic risk factor for SLE.
  • To clarify the association between C4 copy-number variation (CNV) and SLE risk.
  • To differentiate causal effects from linkage disequilibrium with nearby genetic markers.

Main Methods:

  • Genotyping of C4 gene copy numbers (total, C4A, C4B) and a specific C4A exon 29 indel in 2,207 individuals (1,028 SLE cases, 1,179 controls) of European ancestry.
  • Analysis of C4 CNV in conjunction with HLA-DRB1 and MHC region single nucleotide polymorphism (SNP) data.
  • Application of multiple logistic regression to assess the independence of C4 CNV associations from known genetic factors.

Main Results:

  • Genetically determined partial C4 deficiency states were found not to be independent risk factors for SLE in UK and Spanish populations.
  • The C4A exon 29 CT insertion showed no significant association with SLE in either cohort.
  • The study provides strong evidence against a direct causal role for partial C4 deficiency in SLE predisposition.

Conclusions:

  • Partial C4 deficiency states do not independently predispose individuals to systemic lupus erythematosus.
  • Complete C4 deficiency remains a significant genetic risk factor, but partial deficiencies do not share this independent association.
  • These findings refine our understanding of the genetic architecture of SLE and the role of the complement system.

More Related Videos

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Genetic Lingo01:11

Genetic Lingo

Overview